- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Lee Newcomer, MD, MHA, Describes NCCN's Approach to Genetic Testing
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
“There’s a lot of confusion about what tests work and what tests don’t work in pharmacy, at the clinic, and within managed care organizations,” says Dr Newcomer. He adds that the NCCN Biomarkers Compendium’s accessibility and understandability is what makes it a beneficial guide to ensuring the appropriate utilization of genetic testing.
“I think it will help everyone do a little better job of using these tests,” he says.
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
